홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

2-Hydroxyethyl 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydro-2H-1-benzopyran-6-yl butanedioate → Cyclosporine TPGS

HRID 442622
인쇄

반응식

HRID 442622 반응식
[CH3:1][CH2:2][C@@H:3]1[NH:46][C:44](=[O:45])[C@H:43]([C@H:47]([OH:54])[C@@H:48]([CH2:50]/[CH:51]=[CH:52]/[CH3:53])[CH3:49])[N:42]([CH3:55])[C:40](=[O:41])[C@H:39]([CH:56]([CH3:58])[CH3:57])[N:38]([CH3:59])[C:36](=[O:37])[C@H:35]([CH2:60][CH:61]([CH3:63])[CH3:62])[N:34]([CH3:64])[C:32](=[O:33])[C@H:31]([CH2:65][CH:66]([CH3:68])[CH3:67])[N:30]([CH3:69])[C:28](=[O:29])[C@@H:27]([CH3:70])[NH:26][C:24](=[O:25])[C@H:23]([CH3:71])[NH:22][C:20](=[O:21])[C@H:19]([CH2:72][CH:73]([CH3:75])[CH3:74])[N:18]([CH3:76])[C:16](=[O:17])[C@H:15]([CH:77]([CH3:79])[CH3:78])[NH:14][C:12](=[O:13])[C@H:11]([CH2:80][CH:81]([CH3:83])[CH3:82])[N:10]([CH3:84])[C:8](=[O:9])[CH2:7][N:6]([CH3:85])[C:4]1=[O:5].[CH3:86][C:87]1[C:92]([CH3:93])=[C:91]([O:94][C:95]([CH2:97][CH2:98][C:99]([O:101][CH2:102][CH2:103][OH:104])=[O:100])=[O:96])[C:90]([CH3:105])=[C:89]2[CH2:106][CH2:107][C:108]([CH2:111][CH2:112][CH2:113][CH:114]([CH2:116][CH2:117][CH2:118][CH:119]([CH2:121][CH2:122][CH2:123][CH:124]([CH3:126])[CH3:125])[CH3:120])[CH3:115])([CH3:110])[O:109][C:88]=12>C(O)C>[CH3:1][CH2:2][C@@H:3]1[NH:46][C:44](=[O:45])[C@H:43]([C@H:47]([OH:54])[C@@H:48]([CH2:50]/[CH:51]=[CH:52]/[CH3:53])[CH3:49])[N:42]([CH3:55])[C:40](=[O:41])[C@H:39]([CH:56]([CH3:57])[CH3:58])[N:38]([CH3:59])[C:36](=[O:37])[C@H:35]([CH2:60][CH:61]([CH3:62])[CH3:63])[N:34]([CH3:64])[C:32](=[O:33])[C@H:31]([CH2:65][CH:66]([CH3:68])[CH3:67])[N:30]([CH3:69])[C:28](=[O:29])[C@@H:27]([CH3:70])[NH:26][C:24](=[O:25])[C@H:23]([CH3:71])[NH:22][C:20](=[O:21])[C@H:19]([CH2:72][CH:73]([CH3:75])[CH3:74])[N:18]([CH3:76])[C:16](=[O:17])[C@H:15]([CH:77]([CH3:79])[CH3:78])[NH:14][C:12](=[O:13])[C@H:11]([CH2:80][CH:81]([CH3:83])[CH3:82])[N:10]([CH3:84])[C:8](=[O:9])[CH2:7][N:6]([CH3:85])[C:4]1=[O:5].[CH3:86][C:87]1[C:92]([CH3:93])=[C:91]([O:94][C:95]([CH2:97][CH2:98][C:99]([O:101][CH2:102][CH2:103][OH:104])=[O:100])=[O:96])[C:90]([CH3:105])=[C:89]2[CH2:106][CH2:107][C:108]([CH2:111][CH2:112][CH2:113][CH:114]([CH2:116][CH2:117][CH2:118][CH:119]([CH2:121][CH2:122][CH2:123][CH:124]([CH3:126])[CH3:125])[CH3:120])[CH3:115])([CH3:110])[O:109][C:88]=12
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 714062-Hydroxyethyl 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydro-2H-1-benzopyran-6-yl butanedioate3회HCID 5284373Cyclosporin A3회

생성물 1

HCID 131721213Cyclosporine TPGS

시약·촉매·용매 1

HCID 702Ethanol용매
2회

실험 절차

200 mg of Cyclosporine was weighed into a 100 ml beaker and 1.2 grams of Vitamin E TPGS was added, and to this was added 8 grams of ethanol. The ethanol solvent, Cyclosporine, and TPGS were stirred at room temperature for 10 minutes until the Cyclosporine and TPGS components were clearly dissolved. The solvent was evaporated from a Petri dish overnight and the sample was examined under an Olympus BX50 microscope at 200× magnification by adding a small quantity of water to the cyclosporine/TPGS, and watching for visible crystals. No crystals were observed, only a clear solution was obtained. It was therefore concluded that solvent evaporation will also work to produce clear solutions of Cyclosporine/TPGS when added to water.

후처리

  1. additionwas added
  2. dissolutionwere clearly dissolved
  3. customThe solvent was evaporated from a Petri dish overnight
  4. additionby adding a small quantity of water to the cyclosporine/TPGS
  5. customonly a clear solution was obtained
  6. customIt was therefore concluded that solvent evaporation

출처 및 근거

ORD 기록
ord-cf4bd562a0e54fbb9f1accaee1a62c28
출처 데이터셋
uspto-grants-1999_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US05891845

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트